17-N,N-diethylcarbamoyl-4-methyl-4-azaandrostane-3-one

Modify Date: 2024-01-09 19:38:45

17-N,N-diethylcarbamoyl-4-methyl-4-azaandrostane-3-one Structure
17-N,N-diethylcarbamoyl-4-methyl-4-azaandrostane-3-one structure
Common Name 17-N,N-diethylcarbamoyl-4-methyl-4-azaandrostane-3-one
CAS Number 73671-86-0 Molecular Weight 388.59
Density 1.051g/cm3 Boiling Point 528.3ºC at 760 mmHg
Molecular Formula C24H40N2O2 Melting Point N/A
MSDS N/A Flash Point 209.8ºC

 Use of 17-N,N-diethylcarbamoyl-4-methyl-4-azaandrostane-3-one


DMAA is an indirect sympathomimetic amine. DMAA constricts blood vessels and raises blood pressure. DMAA can be used for neurological and cardiovascular disease research[1][2].

 Names

Name (7S,11aR)-N,N-Diethyl-1,4a,6a-trimethyl-2-oxohexadecahydro-1H-ind eno[5,4-f]quinoline-7-carboxamide

  Biological Activity

Description DMAA is an indirect sympathomimetic amine. DMAA constricts blood vessels and raises blood pressure. DMAA can be used for neurological and cardiovascular disease research[1][2].
Related Catalog
References

[1]. Rodricks JV, et al. DMAA as a dietary ingredient. JAMA Intern Med. 2013 Apr 8;173(7):594-5.

[2]. Richard J Bloomer, et al. 1,3-Dimethylamylamine (DMAA): A Brief History and Review of Anecdotal and Laboratory Findings. J Altern Complement Integr Med. 2018 Dec 28.

 Chemical & Physical Properties

Density 1.051g/cm3
Boiling Point 528.3ºC at 760 mmHg
Molecular Formula C24H40N2O2
Molecular Weight 388.59
Flash Point 209.8ºC
Exact Mass 388.30900
PSA 40.62000
LogP 4.27230
Index of Refraction 1.519

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
CL5200000
CHEMICAL NAME :
5-alpha-4-Azaandrostane-17-beta-carboxamide, N,N-diethyl-4-methyl-3-oxo-
CAS REGISTRY NUMBER :
73671-86-0
LAST UPDATED :
199612
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C24-H40-N2-O2
MOLECULAR WEIGHT :
388.66

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
2100 mg/kg
SEX/DURATION :
male 14 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Paternal Effects - testes, epididymis, sperm duct
REFERENCE :
PSEBAA Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- Volume(issue)/page/year: 169,67,1982
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
700 mg/kg
SEX/DURATION :
male 14 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Paternal Effects - prostate, seminal vesicle, Cowper's gland, accessory glands
REFERENCE :
PSEBAA Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- Volume(issue)/page/year: 169,67,1982
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
135 mg/kg
SEX/DURATION :
female 13-21 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - urogenital system
REFERENCE :
PSEBAA Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- Volume(issue)/page/year: 169,67,1982